ChiCTR2000030894 -TOCI, 0 ChiCTR2000030894
tocilizumab vs. favipiravir
COVID 19 all comers
BACC Bay Tocilizumab Trial, 2020 NCT04356937
tocilizumab vs. placebo
COVID 19 all comers
NCT04356937, 0 NCT04356937
tocilizumab vs. placebo
COVID 19 all comers
TOCOVID, 0 NCT04332094
tocilizumab vs. standard of care
COVID 19 all comers
NCT04330638, 0 NCT04330638
tocilizumab vs. standard of care
COVID 19 all comers
TOCIVID (tocilizumab), 0 NCT04322773
tocilizumab vs. standard of care
COVID 19 all comers
Martinez-Sanz, 2020
tocilizumab vs. control
COVID 19 hospitalized
Tsai, 2020
tocilizumab vs. control
COVID 19 hospitalized
HNF Hospital Tocilizumab multidisciplinary team, 2020
tocilizumab vs. control
COVID 19 hospitalized
Colaneri, 2020
tocilizumab vs. control
COVID 19 hospitalized
SAM-COVID-19, 2020
tocilizumab vs. control
COVID 19 hospitalized
EMPACTA, 2020 NCT04372186
tocilizumab vs. placebo
COVID 19 hospitalized
NCT04412772 (ARCHITECTS), 0 NCT04412772
tocilizumab vs. placebo
COVID 19 hospitalized
EU-CTR2020-001748-24 (ImmCoVA), 0 EU-CTR2020-001748-24
tocilizumab vs. standard of care
COVID 19 hospitalized
Rutgers, 2021
tocilizumab vs. standard of care
COVID 19 hospitalized
NCT04479358 (COVIDOSE-2 substudy A 120mg plus 40mg), 0 NCT04479358
tocilizumab vs. standard of care
COVID 19 hospitalized
NCT04434717 (COVITOZ-1 single dose plus two doses), 0 NCT04434717
tocilizumab vs. standard of care
COVID 19 hospitalized
RCT-TCZ-COVID-19, 2021 NCT04346355
tocilizumab vs. standard of care
COVID 19 hospitalized
RECOVERY, 2021 NCT04381936
tocilizumab vs. standard of care
COVID 19 hospitalized
Declercq J (COV-AID), 2021 NCT04330638
tocilizumab vs. standard of care
COVID 19 hospitalized
Dongsheng Wang, 2020 ChiCTR2000029765
tocilizumab vs. standard of care
COVID 19 hospitalized
Soin AS (COVINTOC), 2021 CTRI/2020/05/025369
tocilizumab vs. standard of care
COVID 19 hospitalized
NCT04577534 (COVIDSTORM), 0 NCT04577534
tocilizumab vs. standard of care
COVID 19 hospitalized
EU-CTR2020-001375-32 (PreToVid), 0 EU-CTR2020-001375-32
tocilizumab vs. standard of care
COVID 19 hospitalized
Capra, 2020
tocilizumab vs. control
COVID-19 mild to moderate
NCT04345445, 0 NCT04345445
tocilizumab vs. corticosteroids
COVID-19 mild to moderate
Karakike (ESCAPE), 2021 NCT04339712
tocilizumab vs. anakinra
COVID-19 severe or critically
Somers, 2020
tocilizumab vs. control
COVID-19 severe or critically
Biran, 2020
tocilizumab vs. control
COVID-19 severe or critically
Klopfenstein, 2020
tocilizumab vs. control
COVID-19 severe or critically
Mathilde, 2020
tocilizumab vs. control
COVID-19 severe or critically
TOCI-RAF Study Group (Campochiaro), 2020
tocilizumab vs. control
COVID-19 severe or critically
Andrew, 2020
tocilizumab vs. control
COVID-19 severe or critically
Rashad, 2021 NCT04519385
tocilizumab vs. dexamethasone
COVID-19 severe or critically
CORON-ACT, 0 NCT04335071
tocilizumab vs. placebo
COVID-19 severe or critically
NCT04377750 (HMO-0224-20), 0 NCT04377750
tocilizumab vs. placebo
COVID-19 severe or critically
Rosas (REMDACTA), 2021 NCT04409262
tocilizumab vs. placebo
COVID-19 severe or critically
COVACTA (Rosas), 2020 NCT04320615
tocilizumab vs. placebo
COVID-19 severe or critically
Sarhan, 2022 NCT04779047
tocilizumab vs. remdesivir
COVID-19 severe or critically
ChiCTR2000030580, 0 ChiCTR2000030580
tocilizumab vs. standard of care
COVID-19 severe or critically
CORIMUNO-TOCI-1 (Group 1), 2020 NCT04331808
tocilizumab vs. standard of care
COVID-19 severe or critically
Talaschian, 2021 IRCT20081027001411N4
tocilizumab vs. standard of care
COVID-19 severe or critically
Rojas-Marte, 2020
tocilizumab vs. standard of care
COVID-19 severe or critically
Hamed, 2021
tocilizumab vs. standard of care
COVID-19 severe or critically
REMAP-CAP (tocilizumab), 2021 NCT02735707
tocilizumab vs. standard of care
COVID-19 severe or critically
Karampitsakos, 2021
tocilizumab vs. standard of care
COVID-19 severe or critically
CORIMUNO-TOCI-ICU (Group 2), 2020 NCT04331808
tocilizumab vs. standard of care
COVID-19 severe or critically
Veiga, 2021 NCT04403685
tocilizumab vs. standard of care
COVID-19 severe or critically
Pereira, 2020
tocilizumab vs. standard of care
COVID-19 severe or critically
Sarhan, 2022 NCT04779047
tocilizumab vs. tocilizumab
COVID-19 severe or critically
MARIPOSA, 2021 NCT04363736
tocilizumab vs. tocilizumab
COVID-19 severe or critically
Belhassen-Garc??a, 2021
tocilizumab vs. tocilizumab
COVID-19 severe or critically
